TENX
TENAX THERAPEUTICS, INC.Company Information
- Company Name
- TENAX THERAPEUTICS, INC.
- CIK
- CIK0000034956
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- TENX: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- TENX
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-09-16
- Last sale
- —
- Shares purchased (TTM)
- 1,268,041
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 29,794,130
- Shares outstanding
- 50,869,259
- Ownership
- 58.57%
Earnings Market Reaction
- Filing date
- 2026-07-31
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 118 | 119 | 98 | 99 | 105 | 111 | 95 | 98 | 9 | 13 | 10 | 11 | ||||||
| Prepaid Expense And Other Assets Current | - | - | - | 3 | 0 | - | - | - | - | - | - | - | ||||||
| Prepaid Expense Current | 3 | 4 | 6 | - | - | 1 | 2 | 1 | 1 | 2 | 2 | 0 | ||||||
| Other Assets Current | 0 | 0 | 1 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Current | 122 | 123 | 104 | 103 | 106 | 112 | 97 | 100 | 11 | 14 | 12 | 12 | ||||||
| Assets | 122 | 123 | 104 | 103 | 106 | 112 | 97 | 100 | 11 | 14 | 12 | 12 | ||||||
| Operating Lease Right Of Use Asset | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Other Assets Noncurrent | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Property Plant And Equipment Net | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 7 | 6 | 6 | 6 | 1 | 2 | 3 | 2 | 1 | 1 | 2 | 0 | ||||||
| Accrued Liabilities Current | 1 | 2 | 1 | 1 | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 0 | ||||||
| Liabilities Current | 8 | 8 | 7 | 7 | 3 | 3 | 5 | 3 | 2 | 2 | 4 | 1 | ||||||
| Liabilities | 8 | 8 | 7 | 7 | 3 | 3 | 5 | 3 | 2 | 2 | 4 | 1 | ||||||
Commitments And Contingencies Disclosure | ||||||||||||||||||
| Notes Payable Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 1 | 0 | ||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | 0 | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Liabilities Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Additional Paid In Capital | 515 | 498 | 465 | 448 | 439 | 435 | 407 | 406 | 314 | 313 | 305 | 305 | ||||||
| Retained Earnings Accumulated Deficit | -401 | -383 | -367 | -352 | -336 | -325 | -315 | -309 | -305 | -301 | -297 | -294 | ||||||
| Stockholders Equity | 114 | 115 | 97 | 96 | 103 | 109 | 92 | 97 | 9 | 12 | 8 | 11 | ||||||
| Liabilities And Stockholders Equity | 122 | 123 | 104 | 103 | 106 | 112 | 97 | 100 | 11 | 14 | 12 | 12 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | ||||||
| Common Stock Shares Issued | 32 | 24 | 9 | 6 | 4 | 4 | 3 | 3 | 2 | 2 | 0 | 24 | ||||||
| Shares Outstanding | 32 | 24 | 9 | 6 | 4 | 4 | 3 | 3 | 2 | 2 | 0 | 24 | ||||||
| Preferred Stock Shares Issued | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | - | - | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialTENAX THERAPEUTICS, INC. (TENX) — SEC Financial Statements & Analysis
TENAX THERAPEUTICS, INC. (TENX) is a pharmaceutical preparations company, incorporated in DE. TENAX THERAPEUTICS, INC. trades on Nasdaq as: TENX. TENAX THERAPEUTICS, INC. (TENX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-31. Based on that filing, TENAX THERAPEUTICS, INC. carries a market cap of $740.15M, a P/E ratio of -11.41x, a P/B ratio of 6.52x, a P/S ratio of 195.96x, an enterprise value of $622.17M, and an EV/EBITDA multiple of -9.07x. On profitability, it posts a gross margin of 101.20%, an operating margin of -1816.57%, a net margin of -1717.32%, a Return on Equity (ROE) of -59.80%, a Return on Assets (ROA) of -57.02%, and a Return on Invested Capital (ROIC) of 840.75%. Per share, it reports EPS of $-1.28, diluted EPS of $-1.28, free cash flow per share of $-0.90, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 5.62% year-over-year, net income growth of 106.03% year-over-year, and EPS growth of 60.27% year-over-year. On the balance sheet, it maintains a current ratio of 15.07x, a quick ratio of 14.65x, working capital of $113.59M, a debt-to-equity ratio of 0.07x, a debt ratio of 0.07, an interest coverage ratio of -47231.00x, free cash flow of $-46.03M (TTM), and net debt of $-117.98M. Figures sourced from SEC EDGAR.
- Market Cap
- $740.15M
- P/E TTM
- -11.41x
- EPS TTM
- $-1.28
- P/B TTM
- 6.52x
- ROE TTM
- -59.80%
- ROA TTM
- -57.02%
- Debt To Equity
- 0.07x
- Free Cash Flow TTM
- $-46.03M
- Net Revenue TTM Growth 1Y
- 5.62%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is TENAX THERAPEUTICS, INC. in?
TENAX THERAPEUTICS, INC. (TENX) operates in the Pharmaceutical Preparations industry.
What exchange does TENX trade on?
TENAX THERAPEUTICS, INC. (TENX) trades on the Nasdaq.
Where is TENAX THERAPEUTICS, INC. incorporated?
TENAX THERAPEUTICS, INC. is incorporated in DE.
When was TENAX THERAPEUTICS, INC. (TENX)'s most recent SEC filing?
TENAX THERAPEUTICS, INC. (TENX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-31.
What is TENX's market cap?
TENAX THERAPEUTICS, INC. (TENX) has a market capitalization of $740.15M as of 2026-06-30.
What is TENX's EPS (earnings per share)?
TENAX THERAPEUTICS, INC. (TENX)'s trailing twelve month EPS is $-1.28 as of 2026-06-30.
What is TENX's ROE (return on equity)?
TENAX THERAPEUTICS, INC. (TENX)'s trailing twelve month Return on Equity (ROE) is -59.80% as of 2026-06-30.
What is TENX's ROA (return on assets)?
TENAX THERAPEUTICS, INC. (TENX)'s trailing twelve month Return on Assets (ROA) is -57.02% as of 2026-06-30.
What is TENX's ROIC (return on invested capital)?
TENAX THERAPEUTICS, INC. (TENX)'s trailing twelve month Return on Invested Capital (ROIC) is 840.75% as of 2024-03-31.
What is TENX's EV/EBITDA?
TENAX THERAPEUTICS, INC. (TENX)'s trailing twelve month EV/EBITDA is -9.07x as of 2026-06-30.